Cargando…

Pathology of the human pituitary adenomas

This article describes pertinent aspects of histochemical and molecular changes of the human pituitary adenomas. The article outlines individual tumor groups with general, specific and molecular findings. The discussion further extends to the unusual adenomas or carcinomas. The description in this a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osamura, Robert Y., Kajiya, Hanako, Takei, Mao, Egashira, Noboru, Tobita, Maya, Takekoshi, Susumu, Teramoto, Akira
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522328/ https://www.ncbi.nlm.nih.gov/pubmed/18688636 http://dx.doi.org/10.1007/s00418-008-0472-1

Ejemplares similares

Pathology, Pathogenesis and Therapy of Growth Hormone (GH)-producing Pituitary Adenomas: Technical Advances in Histochemistry and Their Contribution
por: Osamura, Robert Y., et al.
Publicado: (2009)

The Expression of Wnt4 Is Regulated by Estrogen via an Estrogen Receptor Alpha-dependent Pathway in Rat Pituitary Growth Hormone-producing Cells
por: Miyakoshi, Takashi, et al.
Publicado: (2009)

Pituitary Changes in Prop1 Transgenic Mice: Hormone Producing Tumors and Signet-ring Type Gonadotropes
por: Egashira, Noboru, et al.
Publicado: (2008)

TBIO-03. Angiogenesis in Pituitary Adenoma
por: Yoshida, Daizo, et al.
Publicado: (2022)

A Histopathological Study of Multi-hormone Producing Proliferative Lesions in Estrogen-induced Rat Pituitary Prolactinoma
por: Takekoshi, Susumu, et al.
Publicado: (2014)

Inhibitory Effects of Anti-VEGF Antibody on the Growth and Angiogenesis of Estrogen-induced Pituitary Prolactinoma in Fischer 344 Rats: Animal Model of VEGF-targeted Therapy for Human Endocrine Tumors
por: Miyajima, Katsuhiro, et al.
Publicado: (2010)

Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome
por: Umemura, S, et al.
Publicado: (2009)

Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018)

Molecular Morphology of Pituitary Cells, from Conventional Immunohistochemistry to Fluorescein Imaging
por: Matsuno, Akira, et al.
Publicado: (2011)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

The Influence of Endocrine Disrupting Chemicals on the Proliferation of ERα Knockdown-Human Breast Cancer Cell Line MCF-7; New Attempts by RNAi Technology
por: Miyakoshi, Takashi, et al.
Publicado: (2009)

Treatment of Pituitary Carcinomas and Atypical Pituitary Adenomas: A Review
por: HIROHATA, Toshio, et al.
Publicado: (2014)

MicroRNAs in Human Pituitary Adenomas
por: Li, Xu-Hui, et al.
Publicado: (2014)

The Genetics of Pituitary Adenomas
por: Tatsi, Christina, et al.
Publicado: (2019)

Clinical Biology of the Pituitary Adenoma
por: Melmed, Shlomo, et al.
Publicado: (2022)

Mixed gangliocytoma-pituitary adenoma containing GH and GHRH co-secreting adenoma cells
por: Teramoto, Shinichiro, et al.
Publicado: (2019)

Concurrent IgG4-related hypophysitis and clinically nonfunctioning gonadotroph pituitary neuroendocrine tumor
por: Tahara, Shigeyuki, et al.
Publicado: (2023)

Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
por: Koketsu, Kenta, et al.
Publicado: (2015)

Epidemiology of Functioning Pituitary Adenomas
por: Chin, Sang Ouk
Publicado: (2020)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

Pituitary Adenomas: From Diagnosis to Therapeutics
por: Banskota, Samridhi, et al.
Publicado: (2021)

Sprouting Angiogenesis in Human Pituitary Adenomas
por: Zhou, Jie, et al.
Publicado: (2022)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

The Molecular Pathogenesis of Pituitary Adenomas: An Update
por: Jiang, Xiaobing, et al.
Publicado: (2013)

Cytology of Pituitary Adenomas
por: Doniach, I.
Publicado: (1972)

The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019)

Matsuno, A., et al., Molecular Morphology of Pituitary Cells, from Conventional Immunohistochemistry to Fluorescence Imaging. Molecules 2011, 16, 3618-3635
por: Matsuno, Akira, et al.
Publicado: (2012)

Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues
por: Qian, Shehua, et al.
Publicado: (2019)

Disease Modeling of Pituitary Adenoma Using Human Pluripotent Stem Cells
por: Matsumoto, Ryusaku, et al.
Publicado: (2022)

The risks of overlooking the diagnosis of secreting pituitary adenomas
por: Brue, Thierry, et al.
Publicado: (2016)

Role of matrix Metalloproteinases in pituitary adenoma invasion
por: Yang, Chengxian, et al.
Publicado: (2018)

MicroRNAs as Potential Biomarkers in Pituitary Adenomas
por: Donati, Simone, et al.
Publicado: (2021)

The identification of human pituitary adenoma-initiating cells
por: Manoranjan, Branavan, et al.
Publicado: (2016)

Galanin System in Human Glioma and Pituitary Adenoma
por: Falkenstetter, Sarah, et al.
Publicado: (2020)

Sevoflurane Stimulates MAP Kinase Signal transduction through the Activation of PKC α and βII in Fetal Rat Cerebral Cortex Cultured Neuron
por: Hasegawa, Jun, et al.
Publicado: (2006)

Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models
por: Cristina, Carolina, et al.
Publicado: (2014)

Pituitary Adenoma in Pediatric and Adolescent Populations
por: Chen, Jie, et al.
Publicado: (2019)

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014)

Spontaneous intracranial hypotension with pituitary adenoma
por: Firat, A. K., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_hgl6cv1kcevgqdcgvdscn5e8e1